On May 23, 2022 Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, reported that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present in at the Jefferies Healthcare Conference on Wednesday, June 8, 2022, at 3:30 pm ET at the Marriot Marquis in New York City (Press release, Aligos Therapeutics, MAY 23, 2022, View Source [SID1234614941]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies Healthcare Conference
Date: Wednesday, June 8th, 2022
Time: 3:30 to 3:55 pm Eastern Time
Presenter: Lawrence Blatt, Ph.D., MBA, CEO of Aligos
Webcast: Registration Link – Click Here
A replay of the session will be available following the conference for 90-days through the Aligos investor section of the website View Source
The Aligos management team will also participate in investor 1×1 meetings during the conference. Please contact your Jefferies representative to schedule one-on-one meetings with Aligos during the conference.